信息搜索
信息关键字：药
  

共有5246条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]

·益康药业拟投资500万设立全资子公司伊莱诺（山东）生物医药科技有限公司2022-3-1 0:25:42
·鲁班药业2021年净利793.87万同比减少54.88%奥美沙坦中间体产品销售价格下降2022-2-28 23:05:40
·森萱医药2名股东合计减持5万股2021年上半年公司净利7601.14万2022-2-28 22:36:22
·云南白药第一大股东国有股权公司质押5100万股用于担保2022-2-28 22:11:29
·超半数中药上市公司涉足中医医疗服务领域2022-2-28 20:59:32
·智同生物深耕医药行业发展战略结构化升级2022-2-28 16:49:27
·2月28日沪深两市主力资金净流入106.92亿元加仓有色金属、化工、医药生物2022-2-28 16:45:02
·红日药业2021年净利6.88亿同比增长20.03%血必净注射液销售量稳步增长2022-2-28 15:29:48
·红日药业业绩快报：加强资源配置和业务协同2021年净利同比增长两成2022-2-28 15:25:50
·下游制药行业需求强劲迦南科技2021年净利同比增12.15%2022-2-28 14:13:12
·商业贸易行业：华熙生物营收高增华东医药拓展自免管线2022-2-28 13:39:29
·医药行业：防治并举疫苗药物共筑抗疫体系2022-2-28 11:41:14
·融资最新持仓曝光！减仓食品饮料、医药生物、电气设备2022-2-28 9:22:12
·日本药企申请首个新冠口服药上市许可这些公司与其有多年良好合作关系2022-2-28 8:23:44
·祝嘉琦：美国医药供应链安全怎么看？持续看好中国“医药制造”2022-2-28 4:32:59
·南新制药2021年亏损1.76亿同比由盈转亏产品销售收入减少2022-2-27 22:58:17
·医药投向标|辅助生殖首次纳入医保华东医药近7亿美元引入自身免疫创新药英百瑞完成2.3亿元A轮融资2022-2-27 19:30:54
·国药集团与中智集团签署战略合作框架协议2022-2-26 23:15:14
·迪哲医药2021年亏损6.7亿同比亏损增加董事长XIAOLINZHANG薪酬1172.77万2022-2-26 8:43:49
·振东制药2021年净利26.29亿同比增长903.37%出售朗迪制药所致2022-2-26 5:33:34

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]